Haematologica (Nov 2021)

A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia

  • Milena Kohn,
  • Marc Delord,
  • Maureen Chbat,
  • Amina Guemriche,
  • Fatiha Merabet,
  • Anne-Laure Roupie,
  • Naelle Lombion,
  • Hassan Farhat,
  • Thomas Longval,
  • Aurélie Cabannes-Hamy,
  • Juliette Lambert,
  • Stéphanie Marque-Juillet,
  • Victoria Raggueneau,
  • Jennifer Osman,
  • Marc Spentchian,
  • Sophie Rigaudeau,
  • Philippe Rousselot,
  • Caroline Besson

DOI
https://doi.org/10.3324/haematol.2021.280026
Journal volume & issue
Vol. 107, no. 6

Abstract

Read online

No abstracts available.